Lexington biotech Aldeyra is trying once again to win approval for its dry eye disease drug, called reproxalap, after an FDA ...
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...
Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...
Judicial Watch has filed a Freedom of Information Act (FOIA) lawsuit against the U.S. Department of Health and Human Services ...
Discover tailored ADME study options that are tailored to meet specific research goals and accelerate R&D programs.
The primary objective of selecting appropriate nonclinical species for toxicology studies is to ensure the relevance and ...
A performance analysis of the current constituents of the S&P 500 Index Over the Last 30 Years ending September 2024 ...
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ...
Globus Medical continues to grow and expand its orthopedic trauma product portfolio with a new wave of FDA clearances. The company has introduced several new system extensions so far in 2024 and ...
Hidradenitis suppurativa is a chronic, systemic, and often painful skin condition. Here’s what it’s like living with it.